These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
425 related items for PubMed ID: 30626205
21. Cross-talk of receptor activator of nuclear factor-κB ligand signaling with renin-angiotensin system in vascular calcification. Osako MK, Nakagami H, Shimamura M, Koriyama H, Nakagami F, Shimizu H, Miyake T, Yoshizumi M, Rakugi H, Morishita R. Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1287-96. PubMed ID: 23580147 [Abstract] [Full Text] [Related]
24. Role of Wnt/β-Catenin Pathway in the Arterial Medial Calcification and Its Effect on the OPG/RANKL System. Nie B, Zhang SY, Guan SM, Zhou SQ, Fang X. Curr Med Sci; 2019 Feb; 39(1):28-36. PubMed ID: 30868488 [Abstract] [Full Text] [Related]
25. Bone marrow- or vessel wall-derived osteoprotegerin is sufficient to reduce atherosclerotic lesion size and vascular calcification. Callegari A, Coons ML, Ricks JL, Yang HL, Gross TS, Huber P, Rosenfeld ME, Scatena M. Arterioscler Thromb Vasc Biol; 2013 Nov; 33(11):2491-500. PubMed ID: 23990207 [Abstract] [Full Text] [Related]
31. Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway. Zhan JK, Tan P, Wang YJ, Wang Y, He JY, Tang ZY, Huang W, Liu YS. Cardiovasc Diabetol; 2014 Nov 19; 13():153. PubMed ID: 25407893 [Abstract] [Full Text] [Related]
36. [Impact of CD137-CD137L signaling mediated exocytosis of autophagosome within vascular smooth muscle cells on the formation of atherosclerotic calcification]. Li B, Li XY, Zhong W, Shao C, Wang ZQ, Yuan W, Yan JC. Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan 25; 45(1):49-56. PubMed ID: 28100346 [Abstract] [Full Text] [Related]
37. Omentin-1 attenuates arterial calcification and bone loss in osteoprotegerin-deficient mice by inhibition of RANKL expression. Xie H, Xie PL, Wu XP, Chen SM, Zhou HD, Yuan LQ, Sheng ZF, Tang SY, Luo XH, Liao EY. Cardiovasc Res; 2011 Nov 01; 92(2):296-306. PubMed ID: 21750093 [Abstract] [Full Text] [Related]
38. RANKL Inhibits the Production of Osteoprotegerin from Smooth Muscle Cells under Basal Conditions and following Exposure to Cyclic Strain. Davenport C, Harper E, Rochfort KD, Forde H, Smith D, Cummins PM. J Vasc Res; 2018 Nov 01; 55(2):111-123. PubMed ID: 29635231 [Abstract] [Full Text] [Related]
39. TLR4/NF-κB/Ceramide signaling contributes to Ox-LDL-induced calcification of human vascular smooth muscle cells. Song Y, Hou M, Li Z, Luo C, Ou JS, Yu H, Yan J, Lu L. Eur J Pharmacol; 2017 Jan 05; 794():45-51. PubMed ID: 27876618 [Abstract] [Full Text] [Related]